Tag Archives: phase

Allergy Vaccine Passes Phase II Clinical Trial

by on 06. Oct, 2011 in Health

The trial discovered that a regimen from the vaccine enhanced eye allergy responses by 30 % and skin responses by 54 percent. More details: Full article...

Tags: eye allergy, Health, clinical trial, phase, trial, eye…

Read full story • Comments { 0 }

CD4+Foxp3+ regulating T cells suppress γ δ T‐cell effector functions inside a type of T cell‐induced mucosal inflammation

by on 29. Sep, 2011 in Health

Within this study, we investigate functional dynamics of TREG‐cell reactions inside a CD4+ T cell‐induced imitation of intestinal inflammation in αβ T cell‐deficient (TCRβ‐/

Tags: mechanism, cell responses, tcr, intestinal inflammation, phase, Health…

Read full story • Comments { 0 }

The ICOS/ICOSL Path Is Needed for Optimal Antitumor Reactions Mediated by Anti-CTLA-4 Therapy

by on 13. Aug, 2011 in Health

The anti–CTL-connected antigen 4 (anti–CTLA-4) antibody ipilimumab may be the first agent showing enhanced survival inside a randomized phase III trial that enrolled patients with metastatic melanoma. Research is ongoing to recognize systems that elicit clinical benefit within the setting of anti–CTLA-4 therapy. We formerly reported that treated patients had a rise in the regularity of T cells indicating the inducible costimulator (ICOS) molecule, a T-cell–specific molecule that goes towards the CD28/CTLA-4/B7 immunoglobulin superfamily. ICOS and it is ligand (ICOSL) happen to be proven to experience diverse roles in T-cell reactions for example mediating autoimmunity in addition to improving the …

Read full story • Comments { 0 }

SEEK Announces Clinical Evidence Of Effectiveness In Aids Vaccine Phase Ib/II Human Trial

by on 23. Jul, 2011 in Health

SEEK, a independently possessed biopharmaceutical corporation concentrating in immunology, announces today it has completed a Phase Ib/II medical trial of their Aids-v vaccine which demonstrates a 1 log (approximately 90 %) difference in viral count in Aids-infected people in comparison using the placebo collection, after only a single vaccine injection. Gregory Stoloff, Boss of SEEK, said: "This is actually the first age ever that the Aids vaccine has proven this type of significant create a human medical trial... (Source: Health News from Medical News Today) More details: More info...

Tags: Health, Clinical, vaccine, trial, phase…

Read full story • Comments { 0 }

Immunologically restricted patients exhibit a pronounced inflammation and insufficient reaction to hypoxia in fracture hematomas

by on 05. Jul, 2011 in Health

Abstract&pr patients who are recognized to come with an impaired defense mechanisms, bone healing is frequently impaired. Therefore, it's been recommended

that the effectively functioning defense mechanisms may have an relation to the standard of bone healing. Here, we demonstrate

that cells inside the break hematoma of immunologically restricted patients (1) exhibit a disturbed osteogenic differentiation

(normal SPP1 however reduced RUNX2 expression), (2) exhibit a powerful inflammatory reaction (high IL8 and CXCR4), and (3) react on community hypoxia (high expression of HIF1A) though insufficient target gene reactions (reduced LDHA and PGK1 expression). Thus, it's already inside the early inflammatory …

Read full story • Comments { 0 }

Dietary Soy Supplement on Fibromyalgia Symptoms: A Randomized, Double-Blind, Placebo-Controlled, Early Phase Trial

by on 23. Jun, 2011 in Health

This study was a randomized, double-blind, placebo-controlled, early phase trial. Fifty patients seen at a fibromyalgia outpatient treatment program were randomly assigned to a daily soy or placebo (casein) shake. Outcome measures were scores of the Fibromyalgia Impact Questionnaire (FIQ) and the Center for Epidemiologic Studies Depression Scale (CES-D) at baseline and after 6 weeks of intervention. Analysis was with average statistics based on the null hypothesis, and separation check for early phase CAM comparative trials. Twenty-eight patients completed the study. Employ of average statistics with intent-to-treat analysis showed that total FIQ scores decreased by 14% in the soy collection …

Read full story • Comments { 0 }

Quasi-Orthogonal Space-Time Block Coding Using Polynomial Phase Modulation

by on 20. Jun, 2011 in Health

Lately, polynomial phase modulation (Parts per million) was proven to become a ability- and bandwidth-efficient modulation format. Both of these qualities are very popular nowadays specifically in mobile programs, where products with amount, weight, and ability (SWaP) constraints are typical. Within this paper, we propose applying an entire-diversity quasiorthogonal hour-age block code (QOSTBC) using polynomial phase signals as modulation format. QOSTBCs together with Parts per million are utilized to be able to enhance the ability efficiency of communication systems with four transmit antennas. We have the perfect Parts per million constellations that ensure complete diversity and increase the QOSTBC&s …

Read full story • Comments { 0 }

Gem Therapeutics Advances Its Lengthy-Acting Bronchodilator Combination Product Candidate Into Four Additional Phase 2 Studies

by on 17. Jun, 2011 in Health

Gem Therapeutics Corporation. introduced the growth of its dual combination product candidate, PT003 and it is individual components, PT001 and PT005 into a number of plotted Phase 2 studies in patients with moderate-to-severe COPD... (Source: Health News from Medical News Today) More details: Check this...

Tags: phase, Pearl Therapeutics, therapeutics inc, health news, Health, medical…

Read full story • Comments { 0 }

Circassia’s Rapid Four-Dose ToleroMune® Treatment Keeps Significant Decrease In Allergy Signs and symptoms Throughout 12-Month Follow-Up

by on 14. Jun, 2011 in Health

Circassia Ltd, a niche biopharmaceutical corporation centered on allergy, introduced the outcomes of the phase II medical trial showing that patients who received four doses of their ToleroMune® cat allergy vaccine on the 12-week period maintained a statistically significant decrease in signs and symptoms twelve months later... More details: More infos...

Tags: Health, clinical trial, phase, Rapid, Circassia, Allergy…

Read full story • Comments { 0 }

Plasma IL‐6 concentration correlates with clinical disease activity and serum C‐reactive protein concentration in chronic urticaria patients

by on 07. Jun, 2011 in Health

Conclusions and Clinical Relevance

This research stands for evidence that, aside from a residential area cutaneous inflammation, CU is connected having a systemic inflammatory response. Such acute‐phase fact is manifested by elevated circulating IL‐6, which varies together with CRP changes and might be associated with the urticarial activity. (Source: Clinical and Experimental Allergy) More details: Read more...

Tags: plasma, phase, Experimental, Health, Inflammation, systemic inflammatory response…

Read full story • Comments { 0 }
Page 1 of 212